10-67884761-T-C

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2

The NM_012238.5(SIRT1):​c.40T>C​(p.Ser14Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00297 in 1,225,138 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S14A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0023 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0031 ( 7 hom. )

Consequence

SIRT1
NM_012238.5 missense

Scores

1
4
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2B:1

Conservation

PhyloP100: 1.46

Publications

5 publications found
Variant links:
Genes affected
SIRT1 (HGNC:14929): (sirtuin 1) This gene encodes a member of the sirtuin family of proteins, homologs to the yeast Sir2 protein. Members of the sirtuin family are characterized by a sirtuin core domain and grouped into four classes. The functions of human sirtuins have not yet been determined; however, yeast sirtuin proteins are known to regulate epigenetic gene silencing and suppress recombination of rDNA. Studies suggest that the human sirtuins may function as intracellular regulatory proteins with mono-ADP-ribosyltransferase activity. The protein encoded by this gene is included in class I of the sirtuin family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity SIR1_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.0050804913).
BS2
High AC in GnomAd4 at 348 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SIRT1NM_012238.5 linkc.40T>C p.Ser14Pro missense_variant Exon 1 of 9 ENST00000212015.11 NP_036370.2 Q96EB6-1A0A024QZQ1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SIRT1ENST00000212015.11 linkc.40T>C p.Ser14Pro missense_variant Exon 1 of 9 1 NM_012238.5 ENSP00000212015.6 Q96EB6-1

Frequencies

GnomAD3 genomes
AF:
0.00231
AC:
348
AN:
150770
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000925
Gnomad AMI
AF:
0.0684
Gnomad AMR
AF:
0.00250
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00230
Gnomad FIN
AF:
0.0000962
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00285
Gnomad OTH
AF:
0.00242
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
66
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00306
AC:
3285
AN:
1074260
Hom.:
7
Cov.:
31
AF XY:
0.00303
AC XY:
1539
AN XY:
507230
show subpopulations
African (AFR)
AF:
0.000353
AC:
8
AN:
22676
American (AMR)
AF:
0.00133
AC:
11
AN:
8248
Ashkenazi Jewish (ASJ)
AF:
0.0000708
AC:
1
AN:
14116
East Asian (EAS)
AF:
0.0000382
AC:
1
AN:
26208
South Asian (SAS)
AF:
0.00191
AC:
37
AN:
19412
European-Finnish (FIN)
AF:
0.000144
AC:
3
AN:
20896
Middle Eastern (MID)
AF:
0.00138
AC:
4
AN:
2898
European-Non Finnish (NFE)
AF:
0.00338
AC:
3101
AN:
916592
Other (OTH)
AF:
0.00275
AC:
119
AN:
43214
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
180
360
541
721
901
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00231
AC:
348
AN:
150878
Hom.:
4
Cov.:
33
AF XY:
0.00205
AC XY:
151
AN XY:
73654
show subpopulations
African (AFR)
AF:
0.000922
AC:
38
AN:
41210
American (AMR)
AF:
0.00249
AC:
38
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3448
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5072
South Asian (SAS)
AF:
0.00230
AC:
11
AN:
4786
European-Finnish (FIN)
AF:
0.0000962
AC:
1
AN:
10390
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00285
AC:
192
AN:
67450
Other (OTH)
AF:
0.00239
AC:
5
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00221
Hom.:
0
Bravo
AF:
0.00266
ExAC
AF:
0.000490
AC:
12
Asia WGS
AF:
0.000586
AC:
2
AN:
3428

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 14 of the SIRT1 protein (p.Ser14Pro). This variant is present in population databases (rs201230502, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SIRT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1524941). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

SIRT1-related disorder Benign:1
Jun 08, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.42
CADD
Uncertain
24
DANN
Benign
0.96
DEOGEN2
Benign
0.26
T
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.60
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.42
T
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.0051
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.81
L
PhyloP100
1.5
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.63
N
REVEL
Benign
0.048
Sift
Uncertain
0.0080
D
Sift4G
Uncertain
0.053
T
Polyphen
0.0
B
Vest4
0.26
MVP
0.29
MPC
0.48
ClinPred
0.35
T
GERP RS
-0.62
PromoterAI
-0.067
Neutral
Varity_R
0.26
gMVP
0.16
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201230502; hg19: chr10-69644519; COSMIC: COSV53016928; COSMIC: COSV53016928; API